1. 1. Robins-Browne RM, Holt KE, Ingle DJ, Hocking DM, Yang J, Tauschek M. Are Escherichia coli pathotypes still relevant in the era of whole-genome sequencing? Frontiers in cellular and infection microbiology. 2016;6:141. 2. Bono MJ, Reygaert WC. Urinary tract infection. StatPearls [Internet]: StatPearls Publishing
2. 2018. 3. Gillings MR. Integrons: past, present, and future. Microbiol Mol Biol Rev. 2014;78(2):257-77. 4. Partridge SR, Tsafnat G, Coiera E, Iredell JR. Gene cassettes and cassette arrays in mobile resistance integrons. FEMS microbiology reviews. 2009;33(4):757-84. 5. Khoramrooz SS, Sharifi A, Yazdanpanah M, Hosseini SAAM, Emaneini M, Gharibpour F, et al. High frequency of class 1 integrons in Escherichia coli isolated from patients with urinary tract infections in Yasuj, Iran. Iranian Red Crescent Medical Journal. 2016;18(1). 6. Mahon CR, Lehman DC, Manuselis G. Textbook of diagnostic microbiology-e-book: Elsevier Health Sciences
3. 2014. 7. Yousefi A, Torkan S. Uropathogenic Escherichia coli in the Urine Samples of Iranian Dogs: Antimicrobial Resistance Pattern and Distribution of Antibiotic Resistance Genes. BioMed research international. 2017;2017. 8. Performance Standards for Antimicrobial Susceptibility Testing Wayne, PA, USA: Clinical and Laboratory Standards Institute 2017. 9. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417-33. 10. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual: Cold spring harbor laboratory press
4. 1989. 11. Kargar M, Mohammadalipour Z, Doosti A, Lorzadeh S, Japoni-Nejad A. High prevalence of class 1 to 3 integrons among multidrug-resistant diarrheagenic Escherichia coli in southwest of Iran. Osong public health and research perspectives. 2014;5(4):193-8. 12. Wayne P. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing. 2011. 13. El-Hady SA, Adel LA. Occurrence and detection of AmpC β-lactamases among Enterobacteriaceae isolates from patients at Ain Shams University Hospital. Egyptian Journal of Medical Human Genetics. 2015;16(3):239-44. 14. Ranjbar R, Ghazi FM. Antibiotic sensitivity patterns and molecular typing of Shigella sonnei strains using ERIC-PCR. Iranian journal of public health. 2013;42(10):1151. 15. Mandal J, Sangeetha V, Nivedithadivya AD, Parija SC. Characterization of extended-spectrum β-lactamase-producing clinical isolates of Shigella flexneri. Journal of health, population, and nutrition. 2013;31(3):405. 16. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. The Journal of infectious diseases. 2001;183(Supplement_1):S1-S4. 17. Bimanand L, Pakzad I, Sayehmiri K, Yasemi M, Sayehmiri F, Peyman H, et al. Prevalence of Urinary Tract Infection and Associated Microorganisms in Iran
5. A meta-Analysis Study. Research Journal of Pharmaceutical Biological and Chemical Sciences. 2017;8(1):1255-62. 18. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature reviews microbiology. 2015;13(5):269. 19. UTI C-a. CA-UTI. Current Opinion in Infectious Diseases. 2010;23:76-82. 20. Chenoweth CE, Gould CV, Saint S. Diagnosis, management, and prevention of catheter-associated urinary tract infections. Infectious Disease Clinics. 2014;28(1):105-19. 21. Magiorakos AP, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C, et al. Multidrug‐resistant, extensively drug‐resistant and pandrug‐resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection. 2012;18(3):268-81. 22. Hadifar S, Moghoofei M, Nematollahi S, Ramazanzadeh R, Sedighi M, Salehi-Abargouei A, et al. Epidemiology of multi drug resistant uropathogenic Escherichia coli in Iran: a systematic review and meta-analysis. Japanese journal of infectious diseases. 2016:JJID. 2015.652. 23. Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. bmj. 2016;352:i939. 24. Allocati N, Masulli M, Alexeyev MF, Di Ilio C. Escherichia coli in Europe: an overview. International journal of environmental research and public health. 2013;10(12):6235-54. 25. Rezaee MA, Sheikhalizadeh V, Hasani A. Detection of integrons among multi-drug resistant (MDR) Escherichia coli strains isolated from clinical specimens in northern west of Iran. Braz J Microbiol. 2011;42(4):1308-13. Epub 2011/10/01. 26. Masoumian N, Haghi F. Analysis of integrons and associated gene cassettes in clinical isolates of Escherichia coli. J Zanjan Univ Med Sci. 2015;23(99):74-82. 27. Shams F, Hasani A, Rezaee MA, Nahaie MR, Hasani A, Haghi MHSB, et al. Carriage of class 1 and 2 integrons in quinolone, extended-spectrum-β-lactamase-producing and multi drug resistant E. coli and K. pneumoniae: High burden of antibiotic resistance. Advanced pharmaceutical bulletin. 2015;5(3):335. 28. Alizade H. Escherichia coli in Iran: an overview of antibiotic resistance: a review article. Iranian journal of public health. 2018;47(1):1. 29. Pormohammad A, Pouriran R, Azimi H, Goudarzi M. Prevalence of integron classes in Gram-negative clinical isolated bacteria in Iran: a systematic review and meta-analysis. Iranian journal of basic medical sciences. 2019;22(2):118. 30. Yu HS, Lee JC, Kang HY, Ro DW, Chung JY, Jeong YS, et al. Changes in gene cassettes of class 1 integrons among Escherichia coli isolates from urine specimens collected in Korea during the last two decades. Journal of clinical microbiology. 2003;41(12):5429-33. 31. Moghanni M, Ghazvini K, Farsiani H, Namaei MH, Derakhshan M, Yousefi M, et al. High prevalence of sequence type 131 isolates producing CTX-M-15 among extended-spectrum β-lactamase-producing Escherichia coli strains in northeast Iran. Journal of global antimicrobial resistance. 2018;15:74-8. 32. Ghaderi RS, Yaghoubi A, Amirfakhrian R, Hashemy SI, Ghazvini K. The prevalence of genes encoding ESBL among clinical isolates of Escherichia coli in Iran: A systematic review and meta-analysis. Gene Reports. 2020;18:100562. 33. Pana ZD, Zaoutis T. Treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBLs) infections: what have we learned until now? F1000Research. 2018;7. 34. Dalla-Costa LM, Irino K, Rodrigues J, Rivera IN, Trabulsi L. Characterisation of diarrhoeagenic Escherichia coli clones by ribotyping and ERIC-PCR. Journal of medical microbiology. 1998;47(3):227-34. 35. Ying C, Li Y, Wang Y, Zheng B, Yang C. Investigation of the molecular epidemiology of Acinetobacter baumannii isolated from patients and environmental contamination. The Journal of antibiotics. 2015;68(9):562.